KIORA PHARMACEUTICALS INC KPRX
- KIO-301 — Retinitis Pigmentosa Phase 2
Home › Targets › potassium and hyperpolarization-activated cyclic nucleotide-gated voltage gated ion channels
Companies with an active program directed at potassium and hyperpolarization-activated cyclic nucleotide-gated voltage gated ion channels.